Coriolis Pharma

Through an in-depth analysis of clinical trials involving bispecific antibodies, we identified key firms actively working in this modality and provided at least two confirmed contacts for each. This highly targeted list allowed Coriolis Pharma to effectively identify new potential customers and explore additional offerings for their formulation services. The actionable insights from this analysis allowed the Coriolis BD team to enhance its outreach efforts, engage with high-potential clients, and expand its business opportunities in the bispecific antibody space.

Trends Shaping North American Biotech PE / VC Investments


Targeted Lead Generation for Medical Device Clinical Trials


Drivers and Preferences for Outsourced Pharma Testing


Brand / Services Market Awareness and Recognition Benchmarking

Your Shortcut to Smarter Life-Sciences Decisions
Let’s discuss how Nice Insight’s market research and pricing intelligence can deliver actionable insights for your business.